Clinical Trials Logo

Adenosquamous Lung Carcinoma clinical trials

View clinical trials related to Adenosquamous Lung Carcinoma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01294306 Completed - Lung Adenocarcinoma Clinical Trials

MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy

Start date: February 2011
Phase: Phase 2
Study type: Interventional

This phase II trial studies the side effects and how well Akt inhibitor MK2206 (MK2206) and erlotinib hydrochloride works in treating patients with advanced non-small cell lung cancer who have progressed after previous response to erlotinib hydrochloride therapy. MK2206 and erlotinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.